While the government does not seem to be aware of the problem, Stéphane Rambaud, MP for the 3rd constituency of the Var, questions, by means of a written question, the Minister of Health on the shortages of drug supplies that France.
The covid-19 health crisis had, however, been a harbinger of this worrying reality. A Senate commission of inquiry has been created to shed light on this issue. It will also be interested in the economic model of the pharmaceutical industry. The dizzying price of certain particularly innovative treatments now raises the question of everyone’s access to care and the ability of the health system to meet this expense. Pending the conclusion of its work, a question to the government retains all its relevance in view of the dangers posed by these shortages to the health of the French.
WRITTEN QUESTION
Stéphane Rambaud draws the attention of the Minister of Health and Prevention to the supply disruptions of a certain number of medicines in France. Indeed, for several months, many everyday molecules have been out of stock in pharmacies. This situation is dramatic for the management of pathologies and the health of patients, but also endangers the economy of pharmacies. A simple comparison of drug prices at European level shows that France is less attractive, which explains this shortage. On the other hand, no plan for managing drug shortages has been planned by the Government despite the shortcomings already noted during the covid-19 epidemic. This is why he asks him to kindly indicate the urgent measures he intends to take in order to deal with this particularly worrying situation, to secure the supply chain, to relocate and to invent new production models on the national territory, knowing that it is urgent to restore France’s drug supply capacity as soon as possible.
